These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 3490265

  • 1. A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis.
    Briggs DC, Welsh K, Pereira RS, Black CM.
    Arthritis Rheum; 1986 Oct; 29(10):1274-7. PubMed ID: 3490265
    [Abstract] [Full Text] [Related]

  • 2. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
    Venneker GT, van den Hoogen FH, van Meegen M, de Kok-Nazaruk M, Hulsmans RF, Boerbooms AM, de Waal LP, Bos JD, Asghar SS.
    Exp Clin Immunogenet; 1998 Oct; 15(2):90-9. PubMed ID: 9691203
    [Abstract] [Full Text] [Related]

  • 3. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM, Barnard J, Farid N, Marshall WH, Murphy L, Rideout D, Taylor R, Xidos G, Larsen B.
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [Abstract] [Full Text] [Related]

  • 4. C4A gene deletion: association with Graves' disease.
    Ratanachaiyavong S, Lloyd L, McGregor AM.
    J Mol Endocrinol; 1989 Sep; 3(2):145-53. PubMed ID: 2570594
    [Abstract] [Full Text] [Related]

  • 5. C4 complement allotypes in juvenile dermatomyositis.
    Robb SA, Fielder AH, Saunders CE, Davey NJ, Burley MW, Lord DH, Batchelor JR, Dubowitz V.
    Hum Immunol; 1988 May; 22(1):31-8. PubMed ID: 3260584
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity in the structural basis of the human complement C4A null allele (C4A Q0) as revealed by HindIII restriction fragment length polymorphism analysis.
    Uring-Lambert B, Vegnaduzzi N, Carroll MC, Tongio MM, Goetz J, Hauptmann G.
    FEBS Lett; 1987 Jun 08; 217(1):65-8. PubMed ID: 2885219
    [Abstract] [Full Text] [Related]

  • 7. Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus.
    Goldstein R, Arnett FC, McLean RH, Bias WB, Duvic M.
    Arthritis Rheum; 1988 Jun 08; 31(6):736-44. PubMed ID: 3260100
    [Abstract] [Full Text] [Related]

  • 8. DNA polymorphism of major histocompatibility complex class II and class III genes in systemic lupus erythematosus.
    So AK, Fielder AH, Warner CA, Isenberg DA, Batchelor JR, Walport MJ.
    Tissue Antigens; 1990 Mar 08; 35(3):144-7. PubMed ID: 1973860
    [Abstract] [Full Text] [Related]

  • 9. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis.
    Tait B, Mackay IR, Board P, Coggan M, Emery P, Eckardt G.
    Gastroenterology; 1989 Aug 08; 97(2):479-81. PubMed ID: 2787258
    [Abstract] [Full Text] [Related]

  • 10. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
    Pereira S, Black C, Welsh K, Ansell B, Jayson M, Maddison P, Rowell N.
    J Rheumatol; 1987 Aug 08; 14(4):760-5. PubMed ID: 3499513
    [Abstract] [Full Text] [Related]

  • 11. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
    Venneker GT, van Meegen M, de Kok-Nazaruk M, Hulsmans RF, de Waall LP, Bos JD, Asghar SS.
    Exp Clin Immunogenet; 1996 Aug 08; 13(2):104-11. PubMed ID: 9063702
    [Abstract] [Full Text] [Related]

  • 12. A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis.
    Briggs D, Stephens C, Vaughan R, Welsh K, Black C.
    Arthritis Rheum; 1993 Jul 08; 36(7):943-54. PubMed ID: 8318041
    [Abstract] [Full Text] [Related]

  • 13. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
    Fielder AH, Walport MJ, Batchelor JR, Rynes RI, Black CM, Dodi IA, Hughes GR.
    Br Med J (Clin Res Ed); 1983 Feb 05; 286(6363):425-8. PubMed ID: 6401549
    [Abstract] [Full Text] [Related]

  • 14. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans.
    Howard PF, Hochberg MC, Bias WB, Arnett FC, McLean RH.
    Am J Med; 1986 Aug 05; 81(2):187-93. PubMed ID: 3461713
    [Abstract] [Full Text] [Related]

  • 15. Long PCR detection of the C4A null allele in B8-C4AQ0-C4B1-DR3.
    Grant SF, Kristjánsdóttir H, Steinsson K, Blöndal T, Yuryev A, Stefansson K, Gulcher JR.
    J Immunol Methods; 2000 Oct 20; 244(1-2):41-7. PubMed ID: 11033017
    [Abstract] [Full Text] [Related]

  • 16. C4A and C4B null alleles are genetic markers of different types of systemic sclerosis in Japanese patients.
    Takeuchi F, Nabeta H, Hong GH, Matsuta K, Tokunaga K, Tanimoto K, Nakano K.
    Clin Exp Rheumatol; 1998 Oct 20; 16(1):55-60. PubMed ID: 9543562
    [Abstract] [Full Text] [Related]

  • 17. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C, Scholz S, Mehlhaff E, König G, Albert E.
    Arch Dermatol; 1987 Sep 20; 123(9):1188-91. PubMed ID: 3498440
    [Abstract] [Full Text] [Related]

  • 18. Family study of the major histocompatibility complex in HLA DR3 negative patients with systemic lupus erythematosus.
    Batchelor JR, Fielder AH, Walport MJ, David J, Lord DK, Davey N, Dodi IA, Malasit P, Wanachiwanawin W, Bernstein R.
    Clin Exp Immunol; 1987 Nov 20; 70(2):364-71. PubMed ID: 3501348
    [Abstract] [Full Text] [Related]

  • 19. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.
    Hartung K, Baur MP, Coldewey R, Fricke M, Kalden JR, Lakomek HJ, Peter HH, Schendel D, Schneider PM, Seuchter SA.
    J Clin Invest; 1992 Oct 20; 90(4):1346-51. PubMed ID: 1401069
    [Abstract] [Full Text] [Related]

  • 20. HLA antigens and complement C4 allotypes in patients with chronic biologically false positive (CBFP) seroreactions for syphilis: a follow-up study of SLE patients and CBFP reactors.
    Stephansson EA, Koskimies S, Lokki ML.
    Lupus; 1993 Apr 20; 2(2):77-81. PubMed ID: 8330039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.